Cargando…

Adverse Medication Reactions

Cutaneous adverse drug reactions (ADRs) are among the most frequent adverse reactions in patients receiving drug therapy. They have a broad spectrum of clinical manifestations, are caused by various drugs, and result from different pathophysiological mechanisms. Hence, their diagnosis and management...

Descripción completa

Detalles Bibliográficos
Autores principales: Dodiuk-Gad, Roni P., Chung, Wen-Hung, Shear, Neil H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123512/
http://dx.doi.org/10.1007/978-3-319-29785-9_25
_version_ 1783515653300289536
author Dodiuk-Gad, Roni P.
Chung, Wen-Hung
Shear, Neil H.
author_facet Dodiuk-Gad, Roni P.
Chung, Wen-Hung
Shear, Neil H.
author_sort Dodiuk-Gad, Roni P.
collection PubMed
description Cutaneous adverse drug reactions (ADRs) are among the most frequent adverse reactions in patients receiving drug therapy. They have a broad spectrum of clinical manifestations, are caused by various drugs, and result from different pathophysiological mechanisms. Hence, their diagnosis and management is challenging. Severe cutaneous ADRs comprise a group of diseases with major morbidity and mortality, reaching 30 % mortality rate in cases of Toxic Epidermal Necrolysis. This chapter covers the terminology, epidemiology, pathogenesis and classification of cutaneous ADR, describes the severe cutaneous ADRs and the clinical and laboratory approach to the patient with cutaneous ADR and presents the translation of laboratory-based discoveries on the genetic predisposition and pathogenesis of cutaneous ADRs to clinical management guidelines.
format Online
Article
Text
id pubmed-7123512
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-71235122020-04-06 Adverse Medication Reactions Dodiuk-Gad, Roni P. Chung, Wen-Hung Shear, Neil H. Clinical and Basic Immunodermatology Article Cutaneous adverse drug reactions (ADRs) are among the most frequent adverse reactions in patients receiving drug therapy. They have a broad spectrum of clinical manifestations, are caused by various drugs, and result from different pathophysiological mechanisms. Hence, their diagnosis and management is challenging. Severe cutaneous ADRs comprise a group of diseases with major morbidity and mortality, reaching 30 % mortality rate in cases of Toxic Epidermal Necrolysis. This chapter covers the terminology, epidemiology, pathogenesis and classification of cutaneous ADR, describes the severe cutaneous ADRs and the clinical and laboratory approach to the patient with cutaneous ADR and presents the translation of laboratory-based discoveries on the genetic predisposition and pathogenesis of cutaneous ADRs to clinical management guidelines. 2017-04-25 /pmc/articles/PMC7123512/ http://dx.doi.org/10.1007/978-3-319-29785-9_25 Text en © Springer International Publishing Switzerland 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Dodiuk-Gad, Roni P.
Chung, Wen-Hung
Shear, Neil H.
Adverse Medication Reactions
title Adverse Medication Reactions
title_full Adverse Medication Reactions
title_fullStr Adverse Medication Reactions
title_full_unstemmed Adverse Medication Reactions
title_short Adverse Medication Reactions
title_sort adverse medication reactions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123512/
http://dx.doi.org/10.1007/978-3-319-29785-9_25
work_keys_str_mv AT dodiukgadronip adversemedicationreactions
AT chungwenhung adversemedicationreactions
AT shearneilh adversemedicationreactions